Table 1.
First author | Year | Ethnicity | Disease | Number | Gender (M/F) | Age (years) | Genotype method | Gene | SNP | NOS score | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Case | Control | Case | Control | Case | Control | ||||||||
Papagianni A [30] | 2013 | Caucasians | Children | 53 | 45 | 26/27 | – | 5.9±3.9 | – | PCR-RFLP | CD16 | 158 F>V | 6 |
Nourse JP [29] | 2012 | Caucasians | Total | 100 | 100 | – | – | 51 (18~85) | 39 (21~66) | AS-PCR | CD16 | 158 F>V | 6 |
Eyada TK [20] | 2012 | Africans | Children | 92 | 90 | 44/48 | 40/50 | 8.3±4.5 | 6.2±3.5 | PCR-RFLP | CD16 | 131 H>R | 8 |
AS-PCR | CD16 | 158 F>V | |||||||||||
Amorim DM [10] | 2012 | Caucasians | Children | 39 | 78 | 18/21 | 36/42 | 7.3±3.2 | 5.4±4.0 | PCR-RFLP | CD16 | 158 F>V | 7 |
131 H>R | |||||||||||||
Breunis WB [21] | 2008 | Caucasians | Adult | 44 | 100 | 7/37 | – | – | – | MLPA assay | CD32 | 131 H>R | 6 |
Children | 72 | 100 | 35/37 | – | – | – | MLPA assay | CD32 | 131 H>R | 6 | |||
Wang JH [31] | 2007 | Asians | Total | 74 | 111 | 22/52 | 45/66 | 34.5±13.3 | 39.0±16.3 | AS-PCR | CD16 | 158 F>V | 7 |
Carcao MD [26] | 2003 | Caucasians | Children | 98 | 130 | 46/52 | – | 0.5±16.9 | – | PCR-RFLP | CD32 | 158 F>V | 8 |
131 H>R | |||||||||||||
Fujimoto TT [27] | 2001 | Asians | Total | 104 | 59 | 28/76 | 30/29 | 26 | 54.2 | PCR-RFLP | CD32 | 158 F>V | 8 |
131 H>R | |||||||||||||
Foster CB [22] | 2001 | Caucasians | Children/chronic | 36 | 218 | – | – | – | – | PCR-RFLP | CD32 | 158 F>V | 6 |
131 H>R | |||||||||||||
Williams Y [32] | 1998 | Caucasians | Total | 29 | 61 | 30/60 | 10/19 | 7~75 | 20~55 | AS-PCR | CD32 | 131 H>R | 6 |
M – male; F – female; SNP – single nucleotide polymorphism; NOS – Newcastle-Ottawa Scale; PCR-RFLP – polymerase chain reaction-restriction fragment length polymorphism; AS-PCR – allele-specific PCR, MLPA multiplex ligation-dependent probe amplification.